Roy M Bremnes Selected Research

Vascular Endothelial Growth Factors

11/2015	Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.
3/2011	Prognostic impact of angiogenic markers in non-small-cell lung cancer is related to tumor size.
12/2010	Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.
2/2009	VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roy M Bremnes Research Topics

Disease

61	Neoplasms (Cancer) 01/2020 - 05/2002
40	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 11/2005
13	Testicular Neoplasms (Testicular Cancer) 11/2021 - 09/2003
11	Lung Neoplasms (Lung Cancer) 01/2016 - 05/2002
11	Sarcoma (Soft Tissue Sarcoma) 01/2014 - 12/2010
10	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 04/2012
8	Carcinogenesis 01/2019 - 05/2002
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2016 - 12/2002
6	Neoplasm Metastasis (Metastasis) 01/2016 - 05/2002
6	Hypoxia (Hypoxemia) 02/2014 - 11/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2016 - 10/2012
3	Hearing Loss (Hearing Impairment) 11/2016 - 01/2009
3	Tinnitus 11/2016 - 01/2009
2	Ototoxicity 10/2018 - 11/2016
2	Carcinoma (Carcinomatosis) 01/2016 - 10/2002
2	Breast Neoplasms (Breast Cancer) 01/2016 - 04/2011
2	Lymphatic Metastasis 01/2015 - 02/2009
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2012 - 03/2011
2	Neutropenia 07/2011 - 07/2009
2	Margins of Excision 01/2011 - 12/2010
2	Lung Diseases (Lung Disease) 06/2009 - 07/2005
2	Weight Loss (Weight Reduction) 12/2006 - 10/2006
2	Pain (Aches) 10/2006 - 11/2005
1	Second Primary Neoplasms (Neoplasms, Second) 01/2020
1	Disease Progression 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 06/2015
1	Inflammation (Inflammations) 04/2014
1	Adenocarcinoma 11/2012

Drug/Important Bio-Agent (IBA)

13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014 - 02/2006
12	Cisplatin (Platino)FDA LinkGeneric 11/2021 - 12/2002
11	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2002
8	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2015 - 11/2007
7	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2011
6	PlatinumIBA 11/2021 - 08/2010
6	Indicators and Reagents (Reagents)IBA 01/2012 - 11/2007
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 04/2011
5	Estrogen ReceptorsIBA 01/2018 - 04/2011
5	LigandsIBA 04/2017 - 12/2010
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 09/2008
5	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2015 - 11/2007
5	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2012 - 02/2006
4	Hormones (Hormone)IBA 01/2018 - 11/2011
4	Vascular Endothelial Growth FactorsIBA 11/2015 - 02/2009
4	Vascular Endothelial Growth Factor CIBA 01/2015 - 11/2007
3	Protein Isoforms (Isoforms)IBA 01/2018 - 10/2009
3	Aromatase (CYP19)IBA 01/2018 - 01/2016
3	AndrogensIBA 01/2018 - 01/2015
3	SteroidsIBA 01/2018 - 11/2011
3	Carbonic Anhydrase IXIBA 01/2012 - 05/2011
3	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2012 - 05/2011
3	CytokinesIBA 04/2011 - 02/2006
3	Etoposide (VP 16)FDA LinkGeneric 10/2010 - 12/2002
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2016
2	Programmed Cell Death 1 ReceptorIBA 04/2017 - 01/2017
2	Platelet-Derived Growth FactorIBA 01/2014 - 04/2009
2	Macrophage Colony-Stimulating FactorIBA 05/2013 - 05/2012
2	Capsules (Microcapsules)IBA 05/2012 - 02/2012
2	Lactate Dehydrogenase 5IBA 06/2011 - 05/2011
2	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2011 - 01/2011
2	Cadherins (E-Cadherin)IBA 03/2011 - 05/2002
2	Carboplatin (JM8)FDA LinkGeneric 02/2011 - 07/2009
2	Cell-Free Nucleic AcidsIBA 02/2011 - 11/2006
2	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2011 - 11/2006
2	Pemetrexed (MTA)FDA Link 07/2009 - 01/2009
2	Epirubicin (Ellence)FDA LinkGeneric 05/2005 - 12/2002
2	Vincristine (Oncovin)FDA LinkGeneric 05/2005 - 12/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2005 - 12/2002
1	HLA-DR Antigens (HLA-DR)IBA 01/2019
1	PAX6 Transcription FactorIBA 01/2018
1	progesterone receptor BIBA 01/2018
1	B7-H1 AntigenIBA 04/2017
1	AntibodiesIBA 04/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Keratins (Keratin)IBA 01/2016
1	EnzymesIBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	CK-34 beta E12IBA 01/2016
1	ParaffinIBA 01/2016
1	Formaldehyde (Formol)FDA Link 01/2016
1	Keratin-7 (Cytokeratin 7)IBA 01/2016
1	Chemokine CXCL16IBA 10/2015
1	CXC ChemokinesIBA 10/2015
1	Progesterone FDA LinkGeneric 06/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 06/2014
1	SmokeIBA 04/2014
1	XenobioticsIBA 04/2014
1	Angiogenic ProteinsIBA 02/2014
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 02/2014
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 05/2012

Therapy/Procedure

20	Drug Therapy (Chemotherapy) 11/2021 - 12/2002
12	Radiotherapy 11/2021 - 10/2006
10	Therapeutics 01/2018 - 05/2002
7	Aftercare (After-Treatment) 01/2020 - 09/2003
5	Prostatectomy (Retropubic Prostatectomy) 11/2017 - 06/2014
3	Chemoradiotherapy 12/2016 - 06/2014
3	Adjuvant Radiotherapy 05/2013 - 04/2009
1	Image-Guided Radiotherapy 04/2012